Safety of real-time convection-enhanced delivery of liposomes to primate brain: A long-term retrospective

Convection-enhanced delivery (CED) is gaining popularity in direct brain infusions. Our group has pioneered the use of liposomes loaded with the MRI contrast reagent as a means to track and quantitate CED in the primate brain through real-time MRI. When co-infused with therapeutic nanoparticles, the...

Full description

Saved in:
Bibliographic Details
Published inExperimental neurology Vol. 210; no. 2; pp. 638 - 644
Main Authors Krauze, Michal T., Vandenberg, Scott R., Yamashita, Yoji, Saito, Ryuta, Forsayeth, John, Noble, Charles, Park, John, Bankiewicz, Krystof S.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Inc 01.04.2008
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Convection-enhanced delivery (CED) is gaining popularity in direct brain infusions. Our group has pioneered the use of liposomes loaded with the MRI contrast reagent as a means to track and quantitate CED in the primate brain through real-time MRI. When co-infused with therapeutic nanoparticles, these tracking liposomes provide us with unprecedented precision in the management of infusions into discrete brain regions. In order to translate real-time CED into clinical application, several important parameters must be defined. In this study, we have analyzed all our cumulative animal data to answer a number of questions as to whether real-time CED in primates depends on concentration of infusate, is reproducible, allows prediction of distribution in a given anatomic structure, and whether it has long term pathological consequences. Our retrospective analysis indicates that real-time CED is highly predictable; repeated procedures yielded identical results, and no long-term brain pathologies were found. We conclude that introduction of our technique to clinical application would enhance accuracy and patient safety when compared to current non-monitored delivery trials.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0014-4886
1090-2430
DOI:10.1016/j.expneurol.2007.12.015